Related Articles
Challenges in bioinformatics approaches to tumor mutation burden analysis
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer
Circulating microRNAs and their role in the immune response in triple‑negative breast cancer (Review)
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Research progress on immunotherapy in triple‑negative breast cancer (Review)